Trial Profile
Phase 1 Clinical trial of MAN-19 intended to treat complications caused by COVID-19
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs MAN-19 (Primary)
- Indications COVID 2019 infections; SARS-CoV-2 acute respiratory disease
- Focus Adverse reactions
- 29 Dec 2020 According to a Q BioMed media release, the Investigational New Drug (IND) application (or similar clinical trial proposal) to regulators is planned for the first quarter of 2021. This trial is planned to commencing in the first half of 2021.
- 26 Aug 2020 According to a Q BioMed media release, the Phase 1 clinical trial is slated to begin patient enrollment in February 2021 supported by Canadian Government
- 30 Jun 2020 According to a Q BioMed media release, an Investigational New Drug (IND) application (or similar clinical trial proposal) to regulators are planned for late 2020.